{"id":"NCT00414050","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants (V232-057)","officialTitle":"A Study to Assess the Safety, Tolerability, and Immunogenicity of 2 Antigen Doses of Recombinant Hepatitis B Vaccine Manufactured With a Modified Process Administered to Healthy Infants at 2, 4, and 6 Months of Age","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-10-06","primaryCompletion":"2007-10-22","completion":"2007-10-24","firstPosted":"2006-12-21","resultsPosted":"2009-04-14","lastUpdate":"2017-05-23"},"enrollment":1718,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Hepatitis B"],"interventions":[{"type":"BIOLOGICAL","name":"Modified Process Hepatitis B Vaccine (Experimental)","otherNames":[]},{"type":"BIOLOGICAL","name":"Hepatitis B Vaccine (Recombinant)","otherNames":["RECOMBIVAX HB™"]},{"type":"BIOLOGICAL","name":"Hepatitis B Vaccine (Recombinant)","otherNames":["ENGERIX-B®"]}],"arms":[{"label":"Modified Process Hepatitis B vaccine 5 μg","type":"EXPERIMENTAL"},{"label":"RECOMBIVAX HB™ Hepatitis B Vaccine","type":"ACTIVE_COMPARATOR"},{"label":"Modified Process Hepatitis B vaccine 10 μg","type":"EXPERIMENTAL"},{"label":"ENGERIX-B®","type":"ACTIVE_COMPARATOR"}],"summary":"This study was conducted in healthy infants and will provide new immunogenicity and safety data for the modified process hepatitis B vaccine. This study was conducted to address the following: to evaluate the immunogenicity and safety data of the 5 microgram dose of the modified process hepatitis B vaccine compared with a 10 microgram dose of the modified process hepatitis B vaccine, to evaluate another dosing schedule of 2, 4, and 6 months, and to provide descriptive immunogenicity data of another marketed vaccine (ENGERIX-B®).","primaryOutcome":{"measure":"The Percentage of Seroresponders to the Modified Process Hepatitis B Vaccine (5 μg and 10 μg Dose), RECOMBIVAX HB™ Hepatitis B Vaccine (Currently Licensed Vaccine), and ENGERIX-B®","timeFrame":"7 months of age (1 month after 3 doses)","effectByArm":[{"arm":"Modified Process Hepatitis B Vaccine 5 µg (Micrograms)","deltaMin":99.3,"sd":null},{"arm":"RECOMBIVAX™ Hepatitis B Vaccine","deltaMin":98.5,"sd":null},{"arm":"Modified Process Hepatitis B Vaccine 10 µg","deltaMin":100,"sd":null},{"arm":"ENGERIX-B®","deltaMin":99.5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"2 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":1,"exclusionCount":6},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["21552183"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":430},"commonTop":["Injection-site erythema","Irritability","Injection-site swelling","Injection-site pain","Pyrexia"]}}